J. Armitage, M. V. Holmes, and D. Preiss, Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the Week, J. Am. Coll. Cardiol, vol.73, pp.477-487, 2019.

B. F. Voight, Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study, Lancet, vol.380, pp.572-80, 2012.

A. S. Geller, Genetic and secondary causes of severe HDL deficiency and cardiovascular disease, J. Lipid Res, vol.59, pp.2421-2435, 2018.

E. J. Schaefer, A. S. Geller, and G. Endress, The biochemical and genetic diagnosis of lipid disorders, Curr. Opin. Lipidol, vol.30, pp.56-62, 2019.

A. Kontush, HDL particle number and size as predictors of cardiovascular disease, Front. Pharmacol, vol.6, p.218, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01266148

L. Camont, M. J. Chapman, and A. Kontush, Biological activities of HDL subpopulations and their relevance to cardiovascular disease, Trends Mol. Med, vol.17, pp.594-603, 2011.

R. H. Mackey, High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis), J. Am. Coll. Cardiol, vol.60, pp.508-516, 2012.

R. W. Mcgarrah, High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort, Atherosclerosis, vol.246, pp.229-235, 2016.

A. Genoux, Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES Study, BMC Med, vol.14, p.125, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01355624

C. Verdier, Common p2y polymorphisms are associated with plasma inhibitory factor 1 and lipoprotein(a) concentrations, heart rate and body fat mass: The GENES study, Arch. Cardiovasc. Dis, vol.112, pp.124-134, 2019.

G. Hoeke, Short-term cooling increases serum triglycerides and small high-density lipoprotein levels in humans, J. Clin. Lipidol, vol.11, 2017.

V. J. Schettler, NMR-based lipoprotein analysis for patients with severe hypercholesterolemia undergoing lipoprotein apheresis or PCSK9-inhibitor therapy (NAPALI-Study), Ther. Apher. Dial, vol.23, pp.467-473, 2019.

P. J. Blanche, E. L. Gong, T. M. Forte, and A. V. Nichols, Characterization of human high-density lipoproteins by gradient gel electrophoresis, Biochim. Biophys. Acta, vol.665, pp.408-419, 1981.

R. S. Rosenson, HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events, Clin. Chem, vol.57, pp.392-410, 2011.

D. A. Duprez, High Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory Related Events Versus Cardiovascular Events: The Multi Ethnic Study of Atherosclerosis, J. Am. Heart Assoc, vol.4, p.2295, 2015.

K. El-harchaoui, High-density lipoprotein particle size and concentration and coronary risk, Ann. Intern. Med, vol.150, pp.84-93, 2009.

L. H. Kuller, Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome, Atherosclerosis, vol.195, pp.122-130, 2007.

S. Mora, R. J. Glynn, and P. M. Ridker, High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy, Circulation, vol.128, pp.1189-97, 2013.

D. S. Kim, Concentration of Smaller High-Density Lipoprotein Particle (HDL-P) Is Inversely Correlated With Carotid Intima Media Thickening After Confounder Adjustment: The Multi Ethnic Study of Atherosclerosis (MESA), J. Am. Heart Assoc, vol.5, p.2977, 2016.

C. Ditah, Small and medium sized HDL particles are protectively associated with coronary calcification in a cross-sectional population-based sample, Atherosclerosis, vol.251, pp.124-131, 2016.

J. D. Otvos, Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the veterans affairs high-density lipoprotein intervention trial, Circulation, vol.113, pp.1556-1563, 2006.

S. Parish, Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study, Circulation, vol.125, pp.2469-2478, 2012.

I. Poto?njak, Serum Concentration of HDL Particles Predicts Mortality in Acute Heart Failure Patients, Sci. Rep, vol.7, p.46642, 2017.

B. F. Asztalos, Differential effects of HDL subpopulations on cellular ABCA1-and SR-BI-mediated cholesterol efflux, J Lipid Res, vol.46, pp.2246-2253, 2005.

X. Du, HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export, Circ. Res, vol.116, pp.1133-1175, 2015.

A. Zerrad-saadi, HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis, Arterioscler. Thromb. Vasc. Biol, vol.29, pp.2169-75, 2009.

A. Kontush and M. J. Chapman, Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities, Curr. Opin. Lipidol, vol.21, pp.312-320, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00614294

K. Rye, C. A. Bursill, G. Lambert, F. Tabet, and P. J. Barter, The metabolism and anti-atherogenic properties of HDL, J. Lipid Res, vol.50, pp.195-200, 2009.

J. A. De-souza, Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I, J. Cell. Mol. Med, vol.14, pp.608-628, 2010.

M. Gomaraschi, L. Calabresi, and G. Franceschini, Protective Effects of HDL Against Ischemia/Reperfusion Injury, Front. Pharmacol, vol.7, issue.2, 2016.

S. Van-linthout, M. Frias, N. Singh, and B. De-geest, Therapeutic potential of HDL in cardioprotection and tissue repair, Handb. Exp. Pharmacol, vol.224, pp.527-65, 2015.

F. Spillmann, High-density lipoproteins reduce palmitate-induced cardiomyocyte apoptosis in an AMPK-dependent manner, Biochem. Biophys. Res. Commun, vol.466, pp.272-279, 2015.

L. Camont, J. Chapman, and . Kontush, Functionality of HDL particles: Heterogeneity and relationships to cardiovascular disease, Arch. Cardiovasc. Dis. Suppl, vol.3, pp.258-266, 2011.

L. O. Martinez, Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis, Nature, vol.421, pp.75-79, 2003.
URL : https://hal.archives-ouvertes.fr/hal-02678145

P. K. Sandhu, Lipoprotein Biomarkers and Risk of Cardiovascular Disease: A Laboratory Medicine Best Practices (LMBP) Systematic Review, J. Appl. Lab. Med, vol.1, pp.214-229, 2016.

R. J. Deckelbaum, Conversion of human plasma high density lipoprotein-2 to high density lipoprotein-3. Roles of neutral lipid exchange and triglyceride lipases, J. Biol. Chem, vol.261, pp.5201-5209, 1986.

H. Tunstall-pedoe, Myocardial infarction and coronary deaths in the World Health Organization MONICA project: Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents, Circulation, 1994.

S. Kajani, S. Curley, and F. C. Mcgillicuddy, Unravelling hdl-looking beyond the cholesterol surface to the quality within, International Journal of Molecular Sciences, vol.19, p.1971, 2018.

J. P. Kane and M. J. Malloy, Prebeta-1 HDL and coronary heart disease, Current Opinion in Lipidology, vol.23, pp.367-371, 2012.

P. T. Williams, Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease, Atherosclerosis, vol.233, pp.713-733, 2014.

A. Barrans, Hepatic lipase induces the formation of pre-ß1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2, J. Biol. Chem, vol.269, pp.11572-11577, 1994.

X. Collet, Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I, J Lipid Res, vol.40, pp.1185-93, 1999.

C. O. Mendivil, J. Furtado, A. M. Morton, L. Wang, and F. M. Sacks, Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans, Arterioscler. Thromb. Vasc. Biol, vol.36, pp.156-65, 2016.

S. Hascoet, Adiponectin and long-term mortality in coronary artery disease participants and controls, Arterioscler. Thromb. Vasc. Biol, vol.33, pp.19-29, 2013.

A. Genoux, Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES study, J. Lipid Res, vol.54, pp.2550-2558, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-01055265

A. S. Levey, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group, Ann. Intern. Med, vol.130, pp.461-70, 1999.

H. J. Parra, H. Mezdour, N. Ghalim, J. M. Bard, and J. C. Fruchart, Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates, Clin. Chem, vol.36, pp.1431-1435, 1990.

J. Roeykens, Validity and reliability in a Flemish population of the WHO-MONICA Optional Study of Physical Activity Questionnaire, Med. Sci. Sports Exerc, vol.30, pp.1071-1076, 1998.

G. G. Gensini, A more meaningful scoring system for determining the severity of coronary heart disease, Am J Cardiol, vol.51, p.606, 1983.

R. M. Califf, Prognostic value of a coronary artery jeopardy score, J. Am. Coll. Cardiol, vol.5, pp.1055-63, 1985.

P. Ducimetiere, Arteriographically documented coronary artery disease and alcohol consumption in French men. The CORALI Study, Eur. Heart J, vol.14, pp.727-760, 1993.